EndoGastric Solutions Closes Series I Financing at a Total of $45 Million »
May 28, 2019
Participation of Accelmed, a leading medical device investor, validates the compelling market potential of the company’s EsophyX technology REDMOND, Wash. – May 28, 2019 – EndoGastric Solutions® today announced the closing of its Series I financing at a total of $45 million. Accelmed, a leading growth capital medical device investor, joined the round, which had […] More »
EndoGastric Solutions’ TIF 2.0 Procedure Highlighted in Multiple Sessions at DDW 2019 »
May 9, 2019
EGS to host DDW Product Theater session showcasing the evolution of TIF 2.0 procedure along with updates on concomitant hiatal hernia repair REDMOND, Wash. – EndoGastric Solutions® today announced that new data on the Transoral Incisionless Fundoplication (TIF® 2.0) procedure will be presented during multiple sessions at Digestive Disease Week® (DDW®) 2019. These data add […] More »
EndoGastric Solutions® Announces New Data Demonstrating pH Control Following TIF 2.0 and Hiatal Hernia Repair Procedures in GERD Patients »
February 5, 2019
– 95% of patients achieved normal pH exposure levels following concomitant HHR and TIF 2.0 procedures – – GERD-related quality of life and reflux symptom scores also improved significantly – REDMOND, Wash. – EndoGastric Solutions today announced the publication of new clinical data demonstrating high rates of pH normalization and improved clinical outcomes in patients […] More »
GERD Surgery without Incisions »
January 30, 2019
Transoral incisionless fundoplication (TIF) is an attractive alternative for treatment of chronic GERD in patients who meet the criteria for the procedure. by Patricia Salber MD, MBA (@docweighsin) Gastroesophageal reflux disease, also known as GERD, is common, costly, and often chronic. For some people, it may mean taking medications for long periods of time. For […] More »
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 16
- Next Page »